Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fleishaker

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|February 5, 2010
Proof of concept: a PhRMA position paper with recommendations for best practiceM E Cartwright, S Cohen, J C Fleishaker, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Biotransformation of tirilazad in human: 4. effect of finasteride on tirilazad clearance and reduced metabolite formationJ C Fleishaker, P G Pearson, L C Wienkers, et al.
The Journal of Pharmacy and Pharmacology|May 26, 1998
Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in manK Venkatakrishnan, L L von Moltke, S X Duan, et al.
Clinical Pharmacology and Therapeutics|August 1, 1994
Effects of probenecid on the pharmacokinetics and pharmacodynamics of adinazolam in humansP L Golden, P E Warner, J C Fleishaker, et al.
Journal of Clinical Pharmacology|September 1, 1989
Disposition of minoxidil in patients with various degrees of renal functionC E Halstenson, J A Opsahl, C E Wright, et al.
Alimentary Pharmacology & Therapeutics|December 1, 1990
The effect of colestipol dose on postprandial serum bile acid concentration: assessment by an enzymic bioluminescence procedureJ C Fleishaker, S S Rossi, R B Smith, et al.
Journal of Clinical Psychopharmacology|August 1, 1992
Ranitidine does not alter adinazolam pharmacokinetics or pharmacodynamicsA B Suttle, S S Songer, G E Dukes, et al.
Journal of Clinical Pharmacology|May 12, 2000
Pharmacokinetics of single-dose reboxetine in volunteers with renal insufficiencyF Coulomb, F Ducret, J P Laneury, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humansJ C Fleishaker, K K Ryan, J M Jansat, et al.
Psychopharmacology|February 1, 1997
The pharmacokinetics and pharmacodynamics of adinazolam: multi-ethnic comparisonsK Ajir, M Smith, K M Lin, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|February 5, 2010
Proof of concept: a PhRMA position paper with recommendations for best practiceM E Cartwright, S Cohen, J C Fleishaker, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Biotransformation of tirilazad in human: 4. effect of finasteride on tirilazad clearance and reduced metabolite formationJ C Fleishaker, P G Pearson, L C Wienkers, et al.
The Journal of Pharmacy and Pharmacology|May 26, 1998
Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in manK Venkatakrishnan, L L von Moltke, S X Duan, et al.
Clinical Pharmacology and Therapeutics|August 1, 1994
Effects of probenecid on the pharmacokinetics and pharmacodynamics of adinazolam in humansP L Golden, P E Warner, J C Fleishaker, et al.
Journal of Clinical Pharmacology|September 1, 1989
Disposition of minoxidil in patients with various degrees of renal functionC E Halstenson, J A Opsahl, C E Wright, et al.
Alimentary Pharmacology & Therapeutics|December 1, 1990
The effect of colestipol dose on postprandial serum bile acid concentration: assessment by an enzymic bioluminescence procedureJ C Fleishaker, S S Rossi, R B Smith, et al.
Journal of Clinical Psychopharmacology|August 1, 1992
Ranitidine does not alter adinazolam pharmacokinetics or pharmacodynamicsA B Suttle, S S Songer, G E Dukes, et al.
Journal of Clinical Pharmacology|May 12, 2000
Pharmacokinetics of single-dose reboxetine in volunteers with renal insufficiencyF Coulomb, F Ducret, J P Laneury, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humansJ C Fleishaker, K K Ryan, J M Jansat, et al.
Psychopharmacology|February 1, 1997
The pharmacokinetics and pharmacodynamics of adinazolam: multi-ethnic comparisonsK Ajir, M Smith, K M Lin, et al.
Pageof 8